Yan Ming's Form 4 filing
Cytek Biosciences, Inc. (CTKB) · filed Feb 7, 2023
- Accession no.
- 0001209191-23-007670
- Filed
- Feb 7, 2023
- Trade date
- Feb 3, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $14.7K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Yan MingCIK 0001874041 | Director, Officer (Chief Technology Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 3, 2023 | Common Stock | SSaleDisposed | −1,081 | $13.50 | −$14,593.5 | 7,945,752 | Direct | |
| Feb 3, 2023 | Common Stock | SSaleDisposed | −11 | $13.51 | −$148.61 | 7,945,741 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.